Prescription Drugs

• 

  Subject Areas on Research

  • ALSUntangled (ALSU): a scientific approach to off-label treatment options for people with ALS using tweets and twitters. 
  • Abuse and dependence on prescription opioids in adults: a mixture categorical and dimensional approach to diagnostic classification. 
  • Aging and Direct-to-Consumer Prescription Drug Television Ads: The Effects of Individual Differences and Risk Presentation. 
  • An automated causality assessment algorithm to detect drug-induced liver injury in electronic medical record data. 
  • Are prescription drug insurance choices consistent with expected utility theory? 
  • Assessing the present state and potential of Medicaid controlled substance lock-in programs. 
  • Awareness of the Food and Drug Administration's Bad Ad Program and Education Regarding Pharmaceutical Advertising: A National Survey of Prescribers in Ambulatory Care Settings. 
  • Brand Medications and Medicare Part D: How Eye Care Providers' Prescribing Patterns Influence Costs. 
  • Changes in state prescription contraceptive mandates for insurers: the effect on women's contraceptive use. 
  • Characteristics of Clinical Studies Used for US Food and Drug Administration Supplemental Indication Approvals of Drugs and Biologics, 2017 to 2019. 
  • Communicating quantitative risks and benefits in promotional prescription drug labeling or print advertising. 
  • Construct and differential item functioning in the assessment of prescription opioid use disorders among American adolescents. 
  • Correction of misleading information in prescription drug television advertising: The roles of advertisement similarity and time delay. 
  • Cost-related nonadherence in the Medicare program: the impact of Part D. 
  • Deficits and variations in patients' experience with making 9 common medical decisions: the DECISIONS survey. 
  • Development and validation of prescription drug risk, efficacy, and benefit perception measures in the context of direct-to-consumer prescription drug advertising. 
  • Difference in Medication Adherence Between Patients Prescribed a 30-Day Versus 90-Day Supply After Acute Myocardial Infarction. 
  • Differential prescribing of opioid analgesics according to physician specialty for Medicaid patients with chronic noncancer pain diagnoses. 
  • Drugs associated with hepatotoxicity and their reporting frequency of liver adverse events in VigiBase: unified list based on international collaborative work. 
  • Effect of Medicaid Policy Changes on Medication Adherence: Differences by Baseline Adherence. 
  • Enrollment in prescription drug insurance: the interaction of numeracy and choice set size. 
  • Experimental evidence of consumer and physician detection and rejection of misleading prescription drug website content. 
  • Four States With Robust Prescription Drug Monitoring Programs Reduced Opioid Dosages. 
  • Future Challenges and Opportunities in Online Prescription Drug Promotion Research Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters". 
  • Historical Evolution and Provider Awareness of Inactive Ingredients in Oral Medications. 
  • How to align evidence-based benefit design with the employer bottom-line: a case study. 
  • Illicit and nonmedical drug use among older adults: a review. 
  • Impact of FDA Actions, DTCA, and Public Information on the Market for Pain Medication. 
  • Impact of Medicare Part D on mental health treatment and outcomes for dual eligible beneficiaries with HIV. 
  • Improving physician assistant education and practice in SUD and policy recommendations on substance abuse education for physician assistants. 
  • Individual- and Ad-Level Predictors of Perceptions of Serious and Actionable Risks in Direct-to-Consumer Prescription Drug TV Advertising. 
  • Levels of evidence supporting drug, device, and other recommendations in the American Heart Association/American College of Cardiology guidelines. 
  • Medicare Part D Spending on Single-Enantiomer Drugs Versus Their Racemic Precursors. 
  • Medication Use Quality and Safety in Older Adults: 2019 Update. 
  • Medication oversupply in patients with diabetes. 
  • Motives and perceived consequences of nonmedical ADHD medication use by college students: are students treating themselves for attention problems? 
  • Natural Skin Care Products as Adjunctive to Prescription Therapy in Moderate to Severe Rosacea. 
  • Ophthalmic Medication Expenditures and Out-of-Pocket Spending: An Analysis of United States Prescriptions from 2007 through 2016. 
  • Opioid Prescribing in the 2016 Medicare Fee-for-Service Population. 
  • Patient Preferences in Regulatory Benefit-Risk Assessments: A US Perspective. 
  • Patterns of preoperative consultation and surgical specialty in an integrated healthcare system. 
  • Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) Tool for Substance Use Screening in Primary Care Patients. 
  • Pharmacologic studies in vulnerable populations: Using the pediatric experience. 
  • Potential bias in medication adherence studies of prevalent users. 
  • Potential impact of pharmaceutical industry rebates on medication adherence. 
  • Prescription pain reliever abuse and dependence among adolescents: a nationally representative study. 
  • Purposeful learning with drug repurposing. 
  • Relationship between use of electronic health record features and health care quality: results of a statewide survey. 
  • Serious and actionable risks, plus disclosure: Investigating an alternative approach for presenting risk information in prescription drug television advertisements. 
  • Social science and price transparency in direct-to-consumer prescription drug advertisements. 
  • Statin use, intensity, and 3-year clinical outcomes among older patients with coronary artery disease. 
  • Systematic review: reliability of compendia methods for off-label oncology indications. 
  • Taking Repeated Exposure into Account: An Experimental Study of Direct-To-Consumer Prescription Drug Television Ad Effects. 
  • The concentration and persistence of health care expenditures and prescription drug expenditures in Medicare beneficiaries with Alzheimer disease and related dementias. 
  • The impact of evidence-based education on prescribing in a psychiatry residency. 
  • The misuse and diversion of prescribed ADHD medications by college students. 
  • The role of perceived benefits and costs in patients' medical decisions. 
  • The unintended consequences of argument dilution in direct-to-consumer drug advertisements. 
  • Toward digital-based interventions for medication adherence and safety. 
  • Treatment use and barriers among adolescents with prescription opioid use disorders. 
  • Trends and correlates of driving under the influence of alcohol among different types of adult substance users in the United States: a national survey study. 
  • What Are the Incentives for Medicare Prescription Drug Plans to Consider Long-Term Outcomes and Cost? 
  • Who enrolls in the Medicare Part D prescription drug benefit program? Medication use among patients with heart failure. 
• 

  Keywords of People

  • Curtis, Lesley H., Professor in Population Health Sciences, Medicine, General Internal Medicine
  • Wu, Li-Tzy, Professor in Psychiatry and Behavioral Sciences, Medicine, General Internal Medicine